209 related articles for article (PubMed ID: 32398865)
1. LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.
Zhu Z; Song J; Guo Y; Huang Z; Chen X; Dang X; Huang Y; Wang Y; Ou W; Yang Y; Yu W; Liu CY; Cui L
Oncogene; 2020 Jun; 39(24):4666-4680. PubMed ID: 32398865
[TBL] [Abstract][Full Text] [Related]
2. ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner.
Zhu Z; Guo Y; Liu Y; Ding R; Huang Z; Yu W; Cui L; Du P; Goel A; Liu CY
Adv Sci (Weinh); 2023 Nov; 10(32):e2303378. PubMed ID: 37786278
[TBL] [Abstract][Full Text] [Related]
3. High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/FOXO3/CCND1 pathway.
Liu L; Yan X; Wu D; Yang Y; Li M; Su Y; Yang W; Shan Z; Gao Y; Jin Z
J Exp Clin Cancer Res; 2018 Jul; 37(1):178. PubMed ID: 30064475
[TBL] [Abstract][Full Text] [Related]
4. MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway.
Ma D; Liu S; Liu K; Kong L; Xiao L; Xin Q; Jiang C; Wu J
Cancer Biol Ther; 2024 Dec; 25(1):2314324. PubMed ID: 38375821
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway.
Cui FC; Chen Y; Wu XY; Hu M; Qin WS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4212-4223. PubMed ID: 32373957
[TBL] [Abstract][Full Text] [Related]
6. LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway.
Zhang H; Pan YZ; Cheung M; Cao M; Yu C; Chen L; Zhan L; He ZW; Sun CY
Cell Death Dis; 2019 Mar; 10(3):230. PubMed ID: 30850586
[TBL] [Abstract][Full Text] [Related]
7. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
[TBL] [Abstract][Full Text] [Related]
9. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
10. FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role.
Bullock MD; Bruce A; Sreekumar R; Curtis N; Cheung T; Reading I; Primrose JN; Ottensmeier C; Packham GK; Thomas G; Mirnezami AH
Br J Cancer; 2013 Jul; 109(2):387-94. PubMed ID: 23828518
[TBL] [Abstract][Full Text] [Related]
11. Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression.
Zhang D; Huang H; Zheng T; Zhang L; Cui B; Liu Y; Tan S; Zhao L; Tian T; Gao L; Fu Q; Cheng Z; Zhao Y
Front Oncol; 2022; 12():924988. PubMed ID: 35992840
[TBL] [Abstract][Full Text] [Related]
12. CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
Feng Y; Qian W; Zhang Y; Peng W; Li J; Gu Q; Ji D; Zhang Z; Wang Q; Zhang D; Sun Y
BMC Cancer; 2019 Jun; 19(1):576. PubMed ID: 31196027
[TBL] [Abstract][Full Text] [Related]
13. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
14. CDK12 inhibition upregulates ATG7 triggering autophagy via AKT/FOXO3 pathway and enhances anti-PD-1 efficacy in colorectal cancer.
Wu Z; Zhang W; Chen L; Wang T; Wang X; Shi H; Zhang L; Zhong M; Shi X; Mao X; Chen H; Li Q
Pharmacol Res; 2024 Mar; 201():107097. PubMed ID: 38354870
[TBL] [Abstract][Full Text] [Related]
15. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
Li Q; Tang H; Hu F; Qin C
J Cell Biochem; 2019 Mar; 120(3):3853-3860. PubMed ID: 30321450
[TBL] [Abstract][Full Text] [Related]
16. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets.
Nasrollahzadeh A; Momeny M; Fasehee H; Yaghmaie M; Bashash D; Hassani S; Mousavi SA; Ghaffari SH
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119087. PubMed ID: 34182011
[TBL] [Abstract][Full Text] [Related]
18. GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway.
Yu J; Liu M; Liu H; Zhou L
Mol Cell Biochem; 2019 Jul; 457(1-2):191-199. PubMed ID: 31069596
[TBL] [Abstract][Full Text] [Related]
19. Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Huang X; Xiang L; Li Y; Zhao Y; Zhu H; Xiao Y; Liu M; Wu X; Wang Z; Jiang P; Qing H; Zhang Q; Liu G; Zhang W; Li A; Chen Y; Liu S; Wang J
Cell Physiol Biochem; 2018; 47(2):590-603. PubMed ID: 29794466
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived extracellular vesicles delivering TNF-α promotes colorectal cancer metastasis via the NF-kB/LAMB3/AKT axis by targeting SNAP23.
Xie BW; Guan B; Chen W; Zhou M; Gu Q; Liu Y; Yan D
Arch Biochem Biophys; 2023 Jun; 741():109605. PubMed ID: 37086961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
